Harvard University Webinar : Clinical Insights on Race and Social Justice

 

Addressing Health Disparities: Clinical Insights on Race and Social Justice

In the context of the increased attention in the lay and medical press to structural racism in the aftermath of the recent high-profile deaths of African-Americans at the hands of the criminal justice system, this web series will examine the intersections of race and ethnicity, racism, sexual orientation, social justice and health to better understand the myriad ways these important factors lead to health care disparities in our communities.

Register to receive login access, as well as recordings of the sessions after they air. Continuing education credits will be available.

Please note: If you are unable to access the live webinar, the program will be recorded and a link to the recording will be emailed when it becomes available.

Next Webinar: Achieving Equity in Cancer Clinical Trials: Partnering with Communities

Wednesday, November 10, 2021,  1–2 PM ET

Advancements due to cancer clinical trials have significantly reduced cancer mortality over the past decade. However, these advancements are not reaching populations equitably. Barriers inherent in the design, accrual and applicability of cancer clinical trials have resulted in participation among predominantly non-Latinx White and affluent populations with cancer. In this webinar, we will evaluate social justice, clinical trial design, community-based and organizational approaches to overcome structural barriers to ensuring equitable cancer clinical trial participation.

Moderator:

• Manali I. Patel, MD, Assistant Professor, Division of Oncology, Stanford University School of Medicine; Staff Oncologist, VA Palo Alto Health Care System 

Panelists:

• Kim Rhoads, MD, MS, MPH, Associate Director for Community Engagement, University of California San Francisco Comprehensive Cancer Center
• Carmen E. Guerra, MD, MSCE, FACP,  Vice-Chair of Diversity and Inclusion, Department of Medicine, Associate Director of Diversity and Outreach, Abramson Cancer Center, University of Pennsylvania 
• Lola Fashoyin-Aje, MD, MPH, Deputy Director, Division of Oncology 3, OND/CDER, Associate Director Science and Policy to Address Disparities, Oncology Center of Excellence, Food and Drug Administration
• Resource and Registration : Click Here